Aap Implantate Ag · XETR:AAQ1
Aap Implantate — Q1 2019 Earnings Presentation
9 slides from Aap Implantate's earnings presentation, May 13, 2019
Slide 1: aap Implantate AG Q1/2019 Report Conference Call
aap Implantate AG Q1/2019 Report Conference Call Rubino Di Girolamo, CEO Marek Hahn, CFO Berlin, May 13, 2019
Slide 2: Safe Harbor Statement
Safe Harbor Statement Our publication may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual
Slide 3: Key results and progress Q1/2019 (1/2)
Key results and progress Q1/2019 (1/2) ➢ Sales and Earnings ▪ Good start to 2019 with significant sales growth (+26% yoy to EUR 3.5 million) and substantially improved EBITDA (+37% to EUR -1.0 million); sales and EBITDA above the guidance ▪ Double-digit sales growth rates in all regions: Germany (+1
Slide 4: Key results and progress Q1/2019 (2/2)
Key results and progress Q1/2019 (2/2) ➢ LOQTEQ® ▪ Focus on polyaxial fixation technology, plate systems for foot and ankle area as well as sterile packaging for implants ▪ Further focus on adaptation of processes and documents to new regulatory requirements ➢ Silver coating technology ▪ Intensive e
Slide 5: Financial Figures Q1/2019
Financial Figures Q1/2019 (in KEUR) Sales Q1/2019 Q1/2018 Change Trauma 3,451 2,797 +23% Germany 752 656 +15% North America 646 531 +22% North America distributors 630 513 +23% North America global partners 16 18 -11% International (without North America) 2,053 1,610 +28% Europe (without Germany) 65
Slide 6: Highlights Q1/2019 (Balance Sheet)
Highlights Q1/2019 (Balance Sheet) ➢ Total assets 03/31/2019: EUR 41.0 million (12/31/2018: EUR 42.2 million) → -3% ▪ Non-current assets: slightly increased, but countervailing effects − Capitalized development costs: EUR +0.3 million − First-time application IFRS 16 Leases: Increase in other intang
Slide 7: Highlights Q1/2019 (Cash Flow)
Highlights Q1/2019 (Cash Flow) ➢ Operating Cash Flow Q1/2019: EUR -0.5 million (Q1/2018: EUR -1.4 million) ▪ Substantially improved operating result ▪ Positive contribution from working capital of EUR 0.7 million → reduction of inventory (EUR +0.9 million), decreasing receivables (EUR +0.1 million)
Slide 8: Outlook FY/2019
Outlook FY/2019 Q2/2019 – Sales: EUR 2.5 million – EUR 3.5 million (Q2/2018: EUR 2.7 million) – Normalized (recurring) EBITDA: EUR -1.6 million – EUR -1.0 million Reported EBITDA: EUR -2.1 million – EUR -1.5 million (Q2/2018: EUR -1.5 million) FY/2019 – Sales: EUR 13.0 million – EUR 15.0 million (FY
Slide 9: Many thanks for your attention!
Many thanks for your attention! Lorenzweg 5 • 12099 Berlin • Germany Fabian Franke Manager Investor Relations Tel.: +49 30 750 19 – 134 Fax: +49 30 750 19 – 290 E-Mail: ir@aap.de IR-app: 9